Mercados españoles abiertos en 7 hrs 29 min

Ventana Biotech, Inc. (VNTA)

Other OTC - Other OTC Precio demorado. Divisa en USD
Añadir a la lista de favoritos
0,00300,0000 (0,00%)
Al cierre: 11:05AM EDT

Ventana Biotech, Inc.

1 Bachstrasse
Butschwil 9606
Switzerland
41 44 732 60 59

Sector(es)Financial Services
SectorShell Companies
Empleados a tiempo completo

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Ms. Janne ChristensenChief Exec. Officer, Pres, Chief Financial Officer, Treasurer and DirectorN/AN/AN/A
Mr. David HolsworthChief Operating Officer, VP and Exec. DirectorN/AN/AN/A
Ms. Marilyn ThomVP of Admin. & HRN/AN/AN/A
Mr. Elliott MartinVP of Sales and MarketingN/AN/AN/A
Mr. Trevor ConnExec. DirectorN/AN/AN/A
Mr. Yoon YoungkeunSec. and DirectorN/AN/AN/A
Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. The company focuses in the areas of anti-obesity and related illnesses. The company holds rights for the formula for a medicament containing chewing gum with a composition of the extract of hoodia gordonii and 2-hydroxyoleic acid for the treatment of obesity, hypertension, and other metabolic disorders. The company develops appetite suppressant chewing gums, including the low dosage product for the over-the-counter market and the high dosage product for distribution by pharmacists. It intends to market low dosage product though drug and health food stores. The company was formerly known as Personalica, Inc. and changed its name to Ventana Biotech, Inc. in October 2008. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland.

Gobierno corporativo

El ISS Governance QualityScore de Ventana Biotech, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.